From: Study of pulmonary hypertension in post-COVID-19 patients by transthoracic echocardiography
Range | Mean | ± | SD | F-test | p-value | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|
LDH (U/L) | Group I | 110 | – | 652 | 309.00 | ± | 188.54 | 21.340 | 0.001* | P1 | 0.790 |
Group II | 150 | – | 477 | 291.07 | ± | 97.61 | P2 | 0.001* | |||
Group III | 190 | – | 985 | 644.80 | ± | 222.70 | P3 | 0.001* | |||
ESR (mm/hour) | Group I | 10 | – | 110 | 35.20 | ± | 29.75 | 18.705 | 0.001* | P1 | 0.002* |
Group II | 15 | – | 120 | 70.00 | ± | 34.43 | P2 | 0.001* | |||
Group III | 25 | – | 130 | 97.25 | ± | 25.62 | P3 | 0.010* | |||
Serum bilirubin (mg/dL) | Group I | 0.2 | – | 1.1 | 0.59 | ± | 0.30 | 15.183 | 0.001* | P1 | 0.003* |
Group II | 0.2 | – | 1.8 | 0.99 | ± | 0.38 | P2 | 0.001* | |||
Group III | 0.6 | – | 2 | 1.25 | ± | 0.37 | P3 | 0.034* | |||
D-dimer (mg/ FEU) | Group I | 0.2 | – | 1.5 | 0.59 | ± | 0.44 | 8.153 | 0.003* | P1 | 0.093 |
Group II | 0.4 | – | 2.6 | 1.61 | ± | 0.81 | P2 | 0.001* | |||
Group III | 0.3 | – | 9.1 | 2.82 | ± | 2.43 | P3 | 0.035* | |||
PO2 (mmHg) | Group I | 60 | – | 98 | 76.40 | ± | 11.62 | 86.408 | 0.001* | P1 | 0.009* |
Group II | 60 | – | 80 | 68.42 | ± | 5.88 | P2 | 0.001* | |||
Group III | 38 | – | 59 | 42.83 | ± | 5.68 | P3 | 0.001* | |||
SO2% | Group I | 93 | – | 98 | 95.87 | ± | 1.41 | 72.088 | 0.001* | P1 | 0.011* |
Group II | 83 | – | 98 | 91.45 | ± | 4.79 | P2 | 0.001* | |||
Group III | 70.8 | – | 89 | 78.16 | ± | 5.80 | P3 | 0.001* | |||
HCO3 (mEq/L) | Group I | 12 | – | 28 | 24.23 | ± | 4.59 | 0.341 | 0.713 | P1 | 0.451 |
Group II | 22 | – | 29 | 25.40 | ± | 2.50 | P2 | 0.894 | |||
Group III | 12 | – | 29 | 24.43 | ± | 4.86 | P3 | 0.501 | |||
PH | Group I | 7.3 | – | 7.6 | 7.43 | ± | 0.09 | 0.815 | 0.449 | P1 | 0.373 |
Group II | 7.42 | – | 7.53 | 7.47 | ± | 0.03 | P2 | 0.219 | |||
Group III | 7 | – | 7.7 | 7.48 | ± | 0.15 | P3 | 0.777 | |||
PCO2 (mmHg) | Group I | 18 | – | 40 | 32.07 | ± | 6.79 | 0.245 | 0.784 | P1 | 0.841 |
Group II | 26 | – | 42 | 32.67 | ± | 5.25 | P2 | 0.649 | |||
Group III | 15 | – | 60 | 30.80 | ± | 10.44 | P3 | 0.503 |